Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 10 February 2027
- Last conf. stmt
- 27 January 2026
Sharpview Ophthalmology Limited
- Incorporated
- 7 December 2015 (10 years)
- Previously known as
- Syneos Health International Limited (until 30 June 2021)Inc Research International Limited (until 21 December 2018)This list may be incomplete. See all names on Companies House
- Industry
- Other business support service activities n.e.c. (82990)
- Directors
- Max Albrecht Baumann
- Owned by
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- G-05 Davenport House16 Pepper StreetLondonE14 9RP
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 1 active
Officer details are public data from the Companies House register.
Baumann, Max Albrecht
Director · Appointed 24 January 2025
German
Born May 1983 (43)
Officer history (12 former)
24 January 2025
Appointed Baumann, Max Albrecht as Director
25 October 2024
25 October 2024
25 October 2024
Resigned Mayhew, Mark as Director
1 June 2024
Resigned Aliyar, Carol Ann as Director
31 May 2024
Resigned Wojciechowski, Robert Joseph as Director
1 November 2023
Appointed Aliyar, Carol Ann as Director
13 October 2023
1 August 2022
Appointed Wojciechowski, Robert Joseph as Director
10 June 2022
Resigned Featherstone, James Michael, Dr as Director
28 June 2021
28 June 2021
Appointed Mayhew, Mark as Director
28 June 2021
28 June 2021
28 June 2021
Appointed Featherstone, James Michael, Dr as Director
28 June 2021
12 March 2021
Resigned Parks, Robert Alan as Director
1 October 2019
Appointed Parks, Robert Alan as Director
1 October 2019
Resigned Macdonald, Alistair John as Director
24 July 2019
23 July 2019
23 February 2018
23 February 2018
7 December 2015
7 December 2015
Appointed Macdonald, Alistair John as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 28 June 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 13406862
Former controllers (3)
14 January 2025
Ceased Syneos Health Commercial Europe Limited — Owns 25–50% of shares
28 June 2021
Ceased Syneos Health Commercial Europe Limited — Holds 75–100% of voting rights
25 June 2020
Ceased Inc Research Holding Limited — Holds 75–100% of voting rights
Financials
Balance sheet as at 31 December 2024 · total exemption full accounts
- Net Assets
- (£4,344,641)
- Cash
- £63,633
- Employees
- 5
- Debt Ratio
- 362%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Fixed Assets | £626,226 | £761,725 | £897,226 | £865,941 |
| Current Assets | £1,030,247 | £694,861 | £1,076,751 | £2,196,440 |
| Debtors | £841,102 | £182,528 | £96,542 | £279,099 |
| Cash | £63,633 | £386,821 | £980,209 | £1,917,341 |
| Creditors (> 1 year) | £0 | £3,212,367 | £2,920,334 | |
| Net Current Assets | (£4,970,867) | (£4,223,405) | £661,371 | £2,177,746 |
| Net Assets | (£4,344,641) | (£3,461,680) | (£1,653,770) | £123,353 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 12 February 2026 | Confirmation statement with no updates | 27 January 2026 | ||
| 20 August 2025 | Total exemption full accounts | 31 December 2024 | ||
| 29 January 2025 | Total exemption full accounts | 31 December 2023 | ||
| 28 January 2025 | Termination of appointment of a director | |||
| 28 January 2025 | Appointment of a director |
Some other companies at this address
Other companies in this industry
London
Manchester
Langford Lane
London
Bagshot
Aylesbury
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →